fig1
![Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches](https://image.oaes.cc/778e7dd0-42ca-482e-943a-b4249e100d4d/mrr2041.fig.1.jpg)
Figure 1. Baseline gut microbiota differences between responders and non-responders to therapeutics used to treat IBD. IBD: Inflammatory bowel disease.
Figure 1. Baseline gut microbiota differences between responders and non-responders to therapeutics used to treat IBD. IBD: Inflammatory bowel disease.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/